Humana (HUM) Q2 2025 10-Q Quarterly Report

Filed: Jul 30, 2025Period ending Jun 30, 2025

Financials

Hospital & Medical Service PlansSEC EDGAR

Humana (HUM) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 30, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

Humana Q2 2025 10-Q Analysis

Risk Factors

• New risk: Additional impairment charges of $32M for indefinite-lived intangible assets in H1 2025, none recorded in same period 2024, triggered by value creation initiatives
• Most material update: Shift in Medicare Part D benefit design due to Inflation Reduction Act of 2022 causing more level prescription costs and increased plan liabilities risk

+3 more insights

Humana Q2 2025 Quarterly Financials
XBRL

Revenue

$32.4B

▲ +9.6% YoY▲ +0.9% QoQ

Net Income

$545M

▼ -19.7% YoY▼ -56.2% QoQ

Net Margin

1.7%

▼ -62bp YoY▼ -219bp QoQ

Source: XBRL data from Humana Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Humana Quarterly Reports

Q3 2025 10-Q

Get deeper insights on Humana

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.